-
Product Insights
Spotted Quoll Mine
The Spotted Quoll Mine is a nickel mine in Australia. It is currently in operation. Empower your strategies with our Spotted Quoll Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Gain...
-
Thematic Analysis
NewIT Infrastructure Sector Scorecard, Q1 2024 Update – Thematic Intelligence
Cisco continues to lead the thematic screen of GlobalData’s IT infrastructure sector scorecard. The company first took the top spot in Q3 2023 and has maintained it since then, thanks to scores of 5 out of 5 for seven of the screen’s 10 themes.
-
Thematic Analysis
NewTelecom Services Sector Scorecard, Q1 2024 Update – Thematic Intelligence
The thematic screen of GlobalData’s telecom services sector scorecard has shown little sign of change in the first quarter of 2024. The top 10 is the same as it was in Q4 2023, with Telefónica in the top spot ahead of Orange and SK Telecom. Rounding out the top 10 are two US companies (Verizon and AT&T), two European companies (Deutsche Telekom and BT), two Middle Eastern companies (E& and Saudi Telecom), and one Japanese company (NTT).
-
Product Insights
NewLikelihood of Approval Analysis for Diabetic Retinopathy
Overview How likely is it that the drugs in Diabetic Retinopathy will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Diabetic Retinopathy Overview Diabetic retinopathy is a complication of diabetes that affects...
-
Product Insights
NewLikelihood of Approval Analysis for Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)
Overview How likely is it that the drugs in Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Overview Idiopathic...
-
Product Insights
NewLikelihood of Approval Analysis for Salmonella typhi Infections
Overview How likely is it that the drugs in Salmonella typhi Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Salmonella typhi Infections Overview Salmonella Typhi (S. Typhi) are bacteria that...
-
Product Insights
NewLikelihood of Approval Analysis for Pruritus
Overview How likely is it that the drugs in Pruritus will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pruritus Overview Pruritus, or itch, is defined as an unpleasant sensation that provokes...
-
Product Insights
NewLikelihood of Approval Analysis for Uveal Melanoma
Overview How likely is it that the drugs in Uveal Melanoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Uveal Melanoma Overview Uveal melanoma, the most common intraocular tumor, is a...
-
Product Insights
NewLikelihood of Approval Analysis for Cervical Intraepithelial Neoplasia (CIN)
Overview How likely is it that the drugs in Cervical Intraepithelial Neoplasia (CIN) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cervical Intraepithelial Neoplasia (CIN) Overview Cervical intraepithelial neoplasia (CIN), also...
-
Product Insights
NewLikelihood of Approval Analysis for Uveitis
Overview How likely is it that the drugs in Uveitis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Uveitis Overview Uveitis is swelling and irritation of the uvea, the middle layer...